US Edition
AVACEN Announces Two New Patent Approvals for CATHSTA Device in Rapid Succession - Journal of Cyber Policy
Summary by Journal of Cyber Policy
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
AVACEN Announces Two New Patent Approvals for CATHSTA Device in Rapid Succession - Journal of Cyber Policy
AVACEN INC Newest CATHSTA CATHSTA Logo Designed to improve catheter stability during complex cardiac procedures These back-to-back patent approvals mark a significant milestone for AVACEN” — Thomas Muehlbauer CARLSBAD, CA, UNITED STATES, June 26, 2025 /EINPresswire.com/ — AVACEN, Inc., a leader in non-invasive medical device innovation, announced today that it has received two major patent approvals for its CATHeter STAbilization (CATHSTA) devic…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
